FY2025 EPS Estimates for McKesson Boosted by Zacks Research

McKesson Co. (NYSE:MCK) – Analysts at Zacks Research boosted their FY2025 earnings estimates for McKesson in a research report issued to clients and investors on Tuesday, February 25th. Zacks Research analyst R. Department now expects that the company will earn $32.68 per share for the year, up from their previous forecast of $32.43. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Zacks Research also issued estimates for McKesson’s Q4 2025 earnings at $9.70 EPS, Q1 2026 earnings at $8.16 EPS, Q2 2026 earnings at $8.49 EPS, Q4 2026 earnings at $9.52 EPS, FY2026 earnings at $35.73 EPS, Q1 2027 earnings at $8.10 EPS, Q3 2027 earnings at $11.90 EPS and FY2027 earnings at $41.06 EPS.

Other research analysts have also issued research reports about the stock. Evercore ISI boosted their target price on shares of McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a research report on Thursday, February 6th. Bank of America cut their price objective on McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Monday, January 6th. StockNews.com lowered McKesson from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Morgan Stanley upped their price target on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. Finally, Baird R W upgraded shares of McKesson from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 7th. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $645.79.

McKesson Trading Down 0.4 %

Shares of McKesson stock opened at $621.03 on Thursday. The firm has a fifty day simple moving average of $592.91 and a 200-day simple moving average of $563.46. The stock has a market capitalization of $77.83 billion, a price-to-earnings ratio of 28.44, a PEG ratio of 1.29 and a beta of 0.52. McKesson has a 1-year low of $464.42 and a 1-year high of $637.51.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be paid a $0.71 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a yield of 0.46%. McKesson’s payout ratio is currently 13.00%.

Insider Buying and Selling

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the company’s stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total value of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares in the company, valued at $36,276,465.36. This represents a 12.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Leann B. Smith sold 579 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $602.81, for a total value of $349,026.99. Following the transaction, the executive vice president now owns 1,443 shares of the company’s stock, valued at $869,854.83. This represents a 28.64 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 19,268 shares of company stock valued at $11,536,378 over the last quarter. Corporate insiders own 0.11% of the company’s stock.

Hedge Funds Weigh In On McKesson

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Capital A Wealth Management LLC acquired a new position in shares of McKesson in the 4th quarter worth approximately $26,000. Millstone Evans Group LLC bought a new position in McKesson in the 4th quarter valued at $28,000. MidAtlantic Capital Management Inc. acquired a new position in McKesson in the third quarter worth $29,000. RPg Family Wealth Advisory LLC bought a new stake in shares of McKesson during the third quarter worth $31,000. Finally, Synergy Asset Management LLC acquired a new stake in shares of McKesson in the fourth quarter valued at $32,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.